The FDA's decision to ban Red Dye No. 3 isn't the beginning of a transparency movement—it's part of a broader shift that's been reshaping the food industry for years. Consumers today are ...

The clear multistate E. coli outbreak linked to romaine lettuce raises concern about the FDA and transparency — the failure to disclose where consumers purchased the tainted product and who the ...

Functional and cross-functional teams expect greater data transparency to make compliance easier, which would mitigate the risk of drug supply gaps. Every day that a drug isn't available costs a ...

In particular, the guidance outlines how device makers should address transparency and bias and when postmarket monitoring is needed. Troy Tazbaz, director of the FDA’s Digital Health Center of ...

The FDA says companies should keep those imperatives in mind from the earliest stage of device design throughout product marketing authorization. Transparency: The FDA says transparency can ensure ...